News

September 27, 2007 - Sutura Inc., a developer of minimally invasive vascular suturing devices, announced today that the first patient to receive a SuperStitch EL to close a Patent Foramen Ovale (PFO) is showing no left-to-right shunt, demonstrating that a single stitch delivered percutaneously by a transcatheter technique is possible.

Home September 26, 2007
Home
News

September 27, 2007 - UC San Diego Medical Center will break ground today for the $171 million Sulpizio Family ...

Home September 26, 2007
Home
News

September 27, 2007 - Heart experts have released new recommendations designed to increase the number of studies of ...

Home September 26, 2007
Home
News

September 27, 2007 - Cleveland Clinic is hosting two upcoming Summits that will focus on medical innovation and emerging ...

Home September 26, 2007
Home
News

September 26, 2007 - Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging ...

Home September 25, 2007
Home
Case Study

Penn Presbyterian Medical Center, a University of Pennsylvania Health System hospital, is rated one of the top 100 Top Hospitals for cardiovascular care by Solucient — a distinction it has received for five consecutive years. Located in Philadelphia, the 350-bed facility has a long history of providing products and procedures that improve patient care.

Home September 25, 2007
Home
News

September 26, 2007 - Rcadia Medical Imaging Ltd., developer of novel computer-aided diagnostic software, has received a ...

Home September 25, 2007
Home
News

September 25, 2007 - The Medicines Company announced that the FDA has accepted its supplemental new drug application (sNDA) for a modified dosing regimen of Angiomax (bivalirudin) for the treatment of acute coronary syndromes (ACS), specifically in patients with unstable angina or non-segment elevation myocardial infarction (NSTEMI), which could replace heparin in patients undergoing angioplasty.

Home September 24, 2007
Home
News

September 25, 2007 - Cordis Corp. today announced the introduction in the U.S. market of the FIRE STAR Rx PTCA ...

Home September 24, 2007
Home
News

September 25, 2007 - The risk of developing venous thromboembolism while flying on an airplane, a condition known as “economy class syndrome,” is only about one in 5,000 for long flights, although the odds of in-flight clot are higher for some groups, according to a new study out of The Netherlands.

Home September 24, 2007
Home
News

September 25, 2007 - Abbott Laboratories said it is working with the FDA Administration to schedule an advisory panel ...

Home September 24, 2007
Home
Technology

The FIRE STAR Rx PTCA Dilatation Catheter and the DURA STAR Rx PTCA Dilatation Catheter are indicated for expansion in the narrowed area of a coronary artery or bypass graft. The FIRE STAR Balloon features the lowest pre-dilatation profile in the market.

Home September 24, 2007
Home
News

September 25, 2007 - The Sorin Group, a European cardiovascular company, announced today that it has received FDA ...

Home September 24, 2007
Home
News

September 25, 2007 - Abbott enrolled the first patient in HERCULES (Herculink Elite Cobalt Chromium Renal Stent Trial to ...

Home September 24, 2007
Home
News

September 25, 2007 – ScottCare Corp., a noninvasive external counterpulsation (ECP) therapy and cardiopulmonary ...

Home September 24, 2007
Home
Subscribe Now